Singapore markets open in 4 hours 57 minutes

PharmaCyte Biotech, Inc. (PMCB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9800-0.0400 (-1.96%)
At close: 03:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/04/2023
30/04/2022
30/04/2021
30/04/2020
Cash flows from operating activities
Net income
-5,660
-4,316
-4,239
-3,551
-3,827
Stock-based compensation
36.792
645.406
77.956
370.829
748.027
Change in working capital
1,161
-297.166
9.04
-145.608
267.347
Accounts payable
704.238
-242.948
33.1
-13.581
63.958
Other working capital
-4,454
-3,794
-4,117
-3,331
-2,338
Other non-cash items
7.793
174.022
34.846
70.326
473.141
Net cash provided by operating activities
-4,454
-3,794
-4,117
-3,331
-2,338
Cash flows from investing activities
Net cash used for investing activities
0
0
0
0
0
Cash flows from financing activities
Debt repayment
-
0
-50.805
-62.44
-12.352
Common stock issued
31,669
0
87,362
4,699
2,663
Common stock repurchased
-37,968
-13,561
0
-
-0.001
Net cash used provided by (used for) financing activities
-5,526
-13,560
87,311
4,637
2,726
Net change in cash
-9,976
-17,361
83,199
1,307
379.608
Cash at beginning of period
86,939
85,401
2,202
894.861
515.253
Cash at end of period
76,959
68,040
85,401
2,202
894.861
Free cash flow
Operating cash flow
-4,454
-3,794
-4,117
-3,331
-2,338
Free cash flow
-4,454
-3,794
-4,117
-3,331
-2,338